Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2023-08-28 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by 惠州市锦好医疗科技股份有限公司. It includes specifics on the amount raised, usage of funds, bank accounts holding the funds, compliance with regulatory requirements, and changes in the use of funds. The document references regulatory approvals and audit verification related to the fundraising. The content focuses on the actual use and management of capital raised, which aligns with the definition of a Capital/Financing Update (CAP). The document is not an announcement of a report publication, nor is it a full annual or interim financial report. It is a specialized report on fundraising and capital usage, fitting the CAP category.
2023-08-28 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '半年度报告' which translates to 'Half-Year Report' or 'Interim Report'. It contains detailed financial data such as total assets, net profit, earnings per share, and other financial metrics for the reporting period and comparative periods. It also includes company business overview, shareholder information, and other substantive financial and operational data. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of financial statements and comprehensive analysis confirms it is an Interim / Quarterly Report rather than just an announcement or summary. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report.
2023-08-28 Chinese
独立董事关于第二届董事会第二十七次会议有关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding specific board meeting matters related to the company's 2022 stock incentive plan, including cancellation and adjustment of stock options. It references the board meeting and compliance with company articles and legal regulations. The content focuses on board-level decisions and approvals rather than full financial results or audit reports. The document length is short (826 characters) and it is not a report itself but an opinion on board matters. This fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management. It is not an Annual Report, Audit Report, or Regulatory Filing. Therefore, the classification is MANG with high confidence.
2023-08-28 Chinese
关于召开2023年第二次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the company's 2023 second extraordinary general meeting of shareholders (临时股东大会). It details the meeting date, voting methods (including online voting), eligibility, agenda items to be discussed, and procedural information. There is no financial data, no report content, and no results of voting. The document is an announcement about the meeting itself, not the meeting materials or results. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document is relatively short (2341 characters) and focused on meeting logistics and agenda, consistent with PSI rather than AGM Information (which would be presentations/materials shared during the AGM) or Declaration of Voting Results (which would report voting outcomes).
2023-08-28 Chinese
关于注销2022年股权激励计划部分股票期权的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the cancellation of part of the stock options under the 2022 equity incentive plan. It details board and supervisory meetings, approvals, legal opinions, and the reasons for the cancellation of 14,000 stock options due to employees leaving the company. The document is a formal announcement about a change in the company's equity incentive plan, specifically the cancellation of stock options, which relates to capital changes but is not a full financial report or earnings release. It is not a report publication announcement since it contains substantive details about the cancellation and approvals. This fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes such as stock option cancellations.
2023-08-28 Chinese
关于调整公司2022年股权激励计划首次及预留授予股票期权授予数量与行权价格的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding adjustments to the company's 2022 stock incentive plan, specifically about the number of stock options granted and the exercise price. It details board and supervisory meetings, approvals, legal opinions, and the impact of these adjustments. The content focuses on corporate governance and capital structure changes related to stock options and equity incentives. It is not a full financial report, earnings release, or audit report. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement of changes to the stock incentive plan, which falls under capital or financing updates related to equity compensation. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is over 5,000 characters and contains substantive details about the adjustments, not just a brief notice or report publication announcement.
2023-08-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.